Frequent germline BRCA1/2 mutations in women with ovarian cancer and the need for insurance coverage of genetic testing: A Hellenic Society of Medical Oncology (HeSMO) national program
e13525Background: Most international scientific organizations and guidelines recommend genetic counseling and testing for women with epithelial ovarian cancer. Identification of BRCA1/2 mutation ca...